Gillian Dekkers

Title: Gillian Dekkers: Innovator in Antibody Research

Introduction

Gillian Dekkers is a prominent inventor based in Utrecht, Netherlands. She has made significant contributions to the field of antibody research, particularly in the development of therapies targeting complement activation disorders. Her innovative work has led to the creation of novel antibodies that hold promise for various medical applications.

Latest Patents

Gillian Dekkers holds a patent for "Factor H potentiating antibodies and uses thereof." This patent includes isolated, synthetic, or recombinant antibodies and fragments that are specific for factor H. Additionally, it covers nucleic acids or vectors encoding such antibodies and fragments. The applications of these antibodies are crucial for inhibiting complement activation and treating disorders associated with this activation.

Career Highlights

Throughout her career, Gillian has worked with notable organizations, including Gemini Therapeutics Sub, Inc. and Stichting Sanquin Bloedvoorziening. Her experience in these companies has allowed her to advance her research and contribute to the development of innovative therapeutic solutions.

Collaborations

Gillian has collaborated with esteemed colleagues such as Scott Lauder and Tom Purcell. These partnerships have enriched her research and expanded the impact of her work in the scientific community.

Conclusion

Gillian Dekkers is a trailblazer in the field of antibody research, with a focus on complement activation disorders. Her patent and collaborations highlight her commitment to advancing medical science and improving patient outcomes.